Dr. Christine Lee, an Island Health-based clinician scientist, is a nationally renowned researcher working in support of people living with chronic gut disorders, such as inflammatory bowel disease and recurrent Clostridium difficile infection (rCDI).
Dr. Lee’s ground-breaking research essentially allows patients to swallow a capsule that will reconstitute their gut flora, avoiding laborious enemas and significantly increasing access to this remedy for patients in remote and rural locations—a game-changer that can monumentally improve patient care.
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine and includes irritable bowel syndrome, Crohn’s disease, and ulcerative colitis. Its symptoms include abdominal pain, diarrhea, loss of appetite, and weight loss, and can significantly reduce the quality of life for patients and their families. Patients with IBD are at higher risk of developing Clostridium difficile infection, experiencing recurrences, and typically have worse outcomes.